Pain medicine

Opioid-free Anesthesia Protocol on the Early Quality of Recovery after Major Surgery (SOFA Trial): A Randomized Clinical Trial

AnesthesiologyPublished Randomised controlled trial

Primary result · QoR-15Result — go to the resultDifference 6.2 95% CI 0.4–12.0

Authors' conclusion

The opioid-free anesthesia protocol improved quality of recovery after major elective surgery in a statistically but not clinically significant manner when compared to standard anesthesia.

Study context

Population
Patients undergoing scheduled major surgery (excluding bone procedures) typically requiring opioids for postoperative pain135 analysed
Participants
136 patients
Comparison
Opioid-free anesthesia protocol vs standard anesthesia with opioids
  • Opioid-free anesthesian = 67
  • Standardn = 68reference
Primary endpoint
Early postoperative quality of recovery (QoR-15 score)
Follow-up
24 h after surgery
Methodological detailsmonocentric, assessor- and patient-blinded
  • Monocentric
  • Assessor- and patient-blinded

Primary result

QoR-15 · 24 h

Difference

6.2

95% CI 0.4–12.0

P = 0.026

By group

Opioid-free anesthesia

114.9

mean · SD 15.2

Standard

108.7

mean · SD 18.1

Opioid-free anesthesia vs Standard
difference 6.2 (95% CI 0.4–12.0); P = 0.026

As reported in the abstract

Secondary outcomes

QoR-15 · 48 h

QoR-15 differed significantly at 48 h; difference
8.7
95% CI
2.9 to 14.5
P
P = 0.004

QoR-15 · 72 h

QoR-15 differed significantly at 72 h; difference
7.3
95% CI
1.6 to 13.0
P
P = 0.013

Incidence of chronic pain and quality of life · 3 months

No differences in other secondary outcomes

Safety

No major adverse events noticed

Original publication

Opioid-free Anesthesia Protocol on the Early Quality of Recovery after Major Surgery (SOFA Trial): A Randomized Clinical Trial. Anesthesiology. Published 17 November 2023. doi:10.1097/aln.0000000000004840

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.